Prime Medicine Announces Strategic Research Collaboration
Collaboration Combines Prime Medicine’s Precise, Multiplex Gene Editing Capabilities with Bristol Myers Squibb’s Broad Expertise in Development and Commercialization of...
Strategic
CAMP4 Enters Strategic Research Collaboration to Advance
• Collaboration combines BioMarin’s expertise in drug development with CAMP4’s platform-based target discovery capabilities • CAMP4 to receive upfront payment, with...
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
BeyondSpring, Inc.SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by EisaiThe SEED-Eisai Research Collaboration leverages...
